Differential mechanisms of cytochrome P450 inhibition and activation by α-naphthoflavone

Journal of Biological Chemistry

Volumn 272, Issue 6, 1997, Pages 3149-3152

  Koley, Aditya P ^a   Buters, Jeroen T M ^a   Robinson, Richard C ^a   Markowitz, Allen ^b   Friedman, Fred K ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA NAPHTHOFLAVONE; BENZO[A]PYRENE; CYTOCHROME P450;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; ENZYME ACTIVITY; ENZYME INHIBITION; HYDROXYLATION; NONHUMAN; PHOTOLYSIS; PRIORITY JOURNAL; PROTEIN CONFORMATION; RECEPTOR BINDING;

ANIMALIA;

EID: 0031022331     PISSN: 00219258     EISSN: None     Source Type: Journal    
DOI: 10.1074/jbc.272.6.3149     Document Type: Article

References (41)

1. Pierpoint, W. S. (1986) in Plant Flavonoids in Biology and Medicine: Biochemical, Pharmacological, and Structure-Activity Relationships (Cody, V., Middleton, E., Jr., and Harborne, J. B., eds) pp. 125-140, Alan R. Liss, Inc., New York
2. Stavric, B. (1994) Clin. Biochem. 27, 319-332, and references therein
3. Graham, S., Dayal, H., Swanson, M., Mittelman, A., and Wilkinson, G. (1978) J. Natl. Cancer Inst. 61, 709-714
4. Marchand, L. L., Yoshizawa, C. N., Kolonel, L. N., Hankin, J. H., and Goodman, M. T. (1989) J. Natl. Cancer Inst. 81, 1158-1164
5. Wattenberg, L. W., and Leong, J. L. (1970) Cancer Res. 30, 1922-1925
6. Deschner, E. E., Ruperto, J., Wong, G., and Newmark, H. L. (1991) Carcinogenesis 12, 1193-1196
7. Huang, M. T., Wood, A. W., Newmark, H. L., Sayer, J. M., Yagi, H., Jerina, D. M., and Conney, A. H. (1983) Carcinogenesis 4, 1631-1637
8. Chae, Y. H., Marcus, C. B., Ho, D. K., Cassady, J. M., and Baird, W. M. (1991) Cancer Lett. 60, 15-24
9. Das, A., Wang, J. H., and Lein, E. J. (1994) Prog. Drug Res. 42, 133-166, and references therein
10. Siess, M. H., Pennec, A., and Gaydou, E. (1989) Eur. J. Drug. Metab. Pharmacokinet. 14, 235-239
11. Miniscalco, A., Lundahl, J., Regardh, C. G., Edgar, B., and Eriksson, U. G. (1992) J. Pharmacol. Exp. Ther. 261, 1195-1199
12. Tayrlov, I. B., Mikhailenko, V. M., and Gelboin, H. V. (1994) Biochim. Biophys. Acta 1205, 325-335
13. Diamond, L., and Gelboin, H. V. (1969) Science 166, 1023-1025
14. Shou, M., Grogan, J., Mancewicz, J. A., Krausz, K. W., Gonzalez, F. J., Gelboin, H. V., and Korzekwa, K. R. (1994) Biochemistry 33, 6450-6455
15. Johnson, E. F., Schwab, G. E., and Vickery, L. E. (1988) J. Biol. Chem. 263, 17672-17677, and references therein
16. Kinoshita, N., and Gelboin, H. V. (1972) Proc. Natl. Acad. Sci. U. S. A. 69, 824-828
17. Conney, A. H. (1982) Cancer Res. 42, 4875-4917
18. Ioannides, C., and Parke, D. V. (1993) Drug Metab. Rev. 25, 485-501
19. Wrighton, S. A., and Stevens, J. C. (1992) Crit. Rev. Toxicol. 22, 1-21, and references therein
20. Shimada, T., Yun, C.-H., Yamazaki, H., Gautier, J.-C., Beaune, P. H., and Guengerich, F. P. (1992) Mol. Pharmacol. 41, 856-864
21. Mclemore, T. L., Adelberg, S., Liu, M. C., Mcmahon, N. A., Yu, S. J., Hubbard, W. C., Czerwinski, M., Wood, T. G., Storeng, R., Lubert, R. A., Eggleston, J. C., Boyd, M. R., and Hines, R. N. (1990) J. Natl. Cancer. Inst. 82, 1333-1339
22. Nesnow, S. (1979) J. Med. Chem. 22, 1244-1247
23. Friedman, F. K., Wiebel, F. J., and Gelboin, H. V. (1985) Pharmacology 31, 194-202
24. McManus, M. E., Burgess, W. M., Veronese, M. E., Huggett, A., Quattrochi, L. C., and Tukey, R. H. (1990) Cancer Res. 50, 3367-3376
25. Bauer, E., Guo, Z., Ueng, Y.-F., Chastine Bell, L., Zeldin, D., and Guengerich, F. P. (1995) Chem. Res. Toxicol. 8, 136-142
26. Kapitulnik, J., Poppers, P. J., Buening, M. K., Fortner, J. G., and Conney, A. H. (1977) Clin. Pharmacol. Ther. 22, 475-484
27. Buening, M. K., Chang, R. L., Huang, M.-T., Fortner, J. G., Wood, A. W., and Conney, A. H. (1981) Cancer Res. 41, 67-72
28. Shimada, T., Iwasaki, M., Martin, M. V., and Guengerich, F. P. (1989) Cancer Res. 49, 3218-3228
29. Shimada, T., Martin, M. V., Pruess-Schwartz, D., Marnett, L. J., and Guengerich, F. P. (1989) Cancer Res. 49, 6304-6312
30. Yun, C.-H., Shimada, T., and Guengerich, F. P. (1992) Cancer Res. 52, 1868-1874
31. Alben, J. O. (1993) Biophys. J. 65, 1357-1358, and references therein
32. Koley, A. P., Robinson, R. C., Markowitz, A., and Friedman, F. K. (1994) Biochemistry 33, 2484-2489
33. Koley, A. P., Robinson, R. C., Markowitz, A., and Friedman, F. K. (1995) Biochemistry 34, 1942-1947
34. Koley, A. P., Buters, J. T. M., Robinson, R. C., Markowitz, A., and Friedman, F. K. (1995) J. Biol. Chem. 270, 5014-5018
35. Koley, A. P., Buters, J. T. M., Robinson, R. C., Markowitz, A., and Friedman, F. K., (1996) Arch. Biochem. Biophys., in press
36. Buters, J. T. M., Korzekwa, K. R., Kunze, K. L., Omata, Y., Hardwick, J. P., and Gonzalez, F. J. (1994) Drug Metabol. Dispos. 22, 688-692
37. Buters, J. T. M., Shou, M., Hardwick, J. P., Korzekwa, K. R., and Gonzalez, F. J. (1995) Drug Metab. Dispos. 23, 696-701
38. Nebert, D. W., and Gelboin, H. V. (1968) J. Biol. Chem. 243, 6242-6249
39. Yasukochi, Y., and Masters, B. S. S. (1976) J. Biol. Chem. 251, 5337-5344
40. Kenakin, T. (1995) Trends Pharmacol. Sci. 16, 188-192
41. Bruns, R. F. (1996) Trends Pharmacol. Sci. 17, 189